Shanghai Duoning Biotechnology
Shanghai Duoning Biotechnology
Caproasia.com | The leading source of data, research, information & resource for financial professionals, investment managers, professional investors, family offices & advisors to institutions, billionaires, UHNWs & HNWs. Covering capital markets, investments and private wealth in Asia. How do you invest $3 million to $300 million? How do you manage $20 million to $3 billion of assets? Caproasia - Learn more



This site is for accredited investors, professional investors, investment managers and financial professionals only. You should have assets around $3 million to $300 million or managing $20 million to $30 billion.











China One-Stop Bioprocess Company Shanghai Duoning Biotechnology Plans Hong Kong IPO, Raised Funding at $1.4 Billion Valuation in 2023, Founded in 2005 with Current Chairman & CEO Wang Meng Acquiring 60% Stake in 2016 for CNY 180,000, Investors Include Lake Bleu Capital, HongShan Capital Group (Previously Sequoia Capital China), WuXi Biologics, CSPC Pharmaceutical, Akeso & Keymed Biosciences 

19th January | Hong Kong

China one-stop bioprocess company Shanghai Duoning Biotechnology has filed for Hong Kong IPO, having raised funding at $1.4 billion valuation in 2023.  Shanghai Duoning Biotechnology was founded in 2005 with Current Chairman & CEO Wang Meng acquiring 60% stake in 2016 for CNY 180,000.  Shanghai Duoning Biotechnology investors include Lake Bleu Capital, HongShan Capital Group (Previously Sequoia Capital China), WuXi Biologics, CSPC Pharmaceutical, Akeso & Keymed Biosciences.  Shanghai Duoning Biotechnology – Duoning Biotech is a leading one-stop bioprocess solutions provider from China, committed to offering products and services required for the discovery, development and commercialization production of biologics, including reagents, consumables, instruments, equipment, and services. Leveraging our integrated bioprocess system, we empower our customers to achieve effective, reliable, lower-cost and higher-quality biologics manufacturing processes. 

“ China One-Stop Bioprocess Company Shanghai Duoning Biotechnology Plans Hong Kong IPO, Raised Funding at $1.4 Billion Valuation in 2023, Founded in 2005 with Current Chairman & CEO Wang Meng Acquiring 60% Stake in 2016 for CNY 180,000, Investors Include Lake Bleu Capital, HongShan Capital Group (Previously Sequoia Capital China), WuXi Biologics, CSPC Pharmaceutical, Akeso & Keymed Biosciences “

 



- Article continues below -



Intelligence at your fingertips
Get Started ($29 per year) : Click here
Caproasia Subscription ($680 yearly | $70 monthly): Click here


The 2026 Investment Day
Hong Kong | Singapore
March / July / Sept / Oct / Nov

Private Equity, Hedge Funds, Boutique Funds, Private Markets & more. Join 20+ CIOs & Senior investment team, with > 60% single family offices with $300 million AUM. Taking place in Hong Kong and in Singapore. Every March, April, July, Sept, Oct & Nov.
Visit | Register here


The 2026 Family Office Summit
9th / 16th April & 15th Oct Hong Kong Ritz Carlton | 23rd / 30th April & 5th Nov Singapore Amara Sanctuary Resort

Join 60 single family offices & family office professionals in Hong Kong & Singapore
Links: 2026 Family Office Summit | Register here


2026 Investment / Alternatives Summit
March / Oct / Nov in Hong Kong & Singapore

Join leading asset managers, hedge funds, boutique funds, private equity, venture capital & real estate firms in Hong Kong, Singapore & Asia-Pacific at the Investment / Alternatives Summit. Join as delegate, speaker, presenter, partner & sponsor.
Visit | Register here


2026 Private Wealth Summit
April / Oct / Nov in Hong Kong & Singapore

Join CEOs, CIOs, Head of Private Banking, Head of Family Offices & Product Heads at The Private Wealth Summit.  Join as delegate, speaker, presenter, partner & sponsor.
Visit | Register here





 

China One-Stop Bioprocess Company Shanghai Duoning Biotechnology Plans Hong Kong IPO, Raised Funding at $1.4 Billion Valuation in 2023, Founded in 2005 with Current Chairman & CEO Wang Meng Acquiring 60% Stake in 2016 for CNY 180,000, Investors Include Lake Bleu Capital, HongShan Capital Group (Previously Sequoia Capital China), WuXi Biologics, CSPC Pharmaceutical, Akeso & Keymed Biosciences

Shanghai Duoning Biotechnology
Shanghai Duoning Biotechnology



Managing $20 million to $3 billion. Investing $3 million to $300 million.
For Investment Managers, Hedge Funds, Boutique Funds, Private Equity, Venture Capital, Professional Investors, Family Offices, Private Bankers & Advisors, sign up today. Subscribe to Caproasia and receive the latest news, data, insights & reports, events & programs daily at 2 pm.

Join Events & Find Services
Join Investments, Private Wealth, Family Office events in Hong Kong, Singapore, Asia-wide. Find hard-to-find $3 million to $300 million financial & investment services at The Financial Centre | TFC. Find financial, investment, private wealth, family office, real estate, luxury investments, citizenship, law firms & more.  List hard-to-find financial & private wealth services.

Have a product launch? Promote a product or service? List your service at The Financial Centre | TFC. Join interviews & editorial and be featured on Caproasia.com or join Investments, Private Wealth, Family Office events. Contact us at [email protected] or [email protected]

Caproasia.com | The leading source of data, research, information & resource for financial professionals, investment managers, professional investors, family offices & advisors to institutions, billionaires, UHNWs & HNWs. Covering capital markets, investments and private wealth in Asia. How do you invest $3 million to $300 million? How do you manage $20 million to $3 billion of assets?



Quick Links



Web links may be disabled on mobile for security.
Please click on desktop.










Caproasia Users

  • Manage $20 million to $30 billion of assets
  • Invest $3 million to $300 million
  • Advise institutions, billionaires, UHNWs & HNWs

Caproasia Platforms | 11,000 Investors & Advisors

Monthly Roundtable & Networking

Family Office Programs

The 2026 Investment Day

  • March - Hong Kong
  • March - Singapore
  • April - Hong Kong
  • April - Singapore
  • July - Hong Kong
  • July - Singapore
  • Sept- Hong Kong
  • Sept - Singapore
  • Oct- Hong Kong
  • Nov - Singapore
  • Visit: The Investment Day | Register: Click here

Caproasia Summits

Contact Us

For Enquiries, Membership
[email protected], [email protected]

For Listing, Subscription
[email protected], [email protected]

For Press Release, send to:
[email protected]

For Events & Webinars
[email protected]

For Media Kit, Advertising, Sponsorships, Partnerships
[email protected]

For Research, Data, Surveys, Reports
[email protected]

For General Enquiries
[email protected]





Caproasia | Driving the future of Asia
a financial information technology co.
since 2014